Detalhe da pesquisa
1.
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
N Engl J Med
; 388(9): 813-823, 2023 Mar 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36856617
2.
DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APC.
Cell
; 142(6): 930-42, 2010 Sep 17.
Artigo
Inglês
| MEDLINE | ID: mdl-20850014
3.
Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodies.
J Oncol Pharm Pract
; 27(3): 555-559, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32423325
4.
Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma.
Acta Oncol
; 59(4): 434-437, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-31920132
5.
Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with BRAF V600-mutant tumours.
Br J Clin Pharmacol
; 84(4): 764-775, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29243287
6.
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.
Lancet Oncol
; 17(11): 1558-1568, 2016 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-27622997
7.
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Cancer
; 122(23): 3641-3649, 2016 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27648727
8.
Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2.
Cancer Immunol Immunother
; 65(8): 941-9, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27277816
9.
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.
Lancet Oncol
; 16(4): 375-84, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25795410
10.
Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp.
J Am Acad Dermatol
; 70(3): 435-42, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24373782
11.
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity.
Cancer Discov
; : OF1-OF15, 2024 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38588588
12.
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review.
Cancers (Basel)
; 15(9)2023 Apr 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37174027
13.
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial.
Nat Med
; 29(9): 2278-2285, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37592104
14.
Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme.
J Neurooncol
; 110(2): 257-64, 2012 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-22932984
15.
Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma.
Cancer Discov
; 12(3): 644-653, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34764195
16.
The dark side of immunotherapy.
Ann Transl Med
; 9(12): 1041, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-34277841
17.
Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanoma.
J Immunother Cancer
; 9(1)2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33500258
18.
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma.
J Immunother Cancer
; 9(6)2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34117113
19.
Adjuvant treatment for patients with surgically resected advanced-stage melanoma.
Clin Adv Hematol Oncol
; 13(10): 633-5, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-27058564
20.
Recurrence risk of early-stage melanoma of the external ear: an investigation of surgical approach and sentinel lymph node status.
Melanoma Res
; 30(2): 173-178, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31219456